GoKawiilNature Neuroscience issues correction to competing interests statement on endocannabinoid reward study
The journal has published an author correction to a study on endocannabinoids and reward engagement, updating the competing interests disclosure. The revised statement discloses that several authors are co-founders, board members, or the CEO of Biosyft, LLC, a company developing technologies related to the paper's subject matter. The correction applies to both the HTML and PDF versions of the article.
GoKawiil's interpretation of the reporting above, not reported fact.
Accurate competing interests disclosures are essential for readers to properly evaluate potential conflicts of interest influencing research design or interpretation. This correction highlights ongoing scrutiny of financial ties between academic researchers and commercial ventures built on their own findings, even when the specific study isn't directly tied to current product lines.
- The correction only changes the competing interests section, not the scientific findings themselves.
- Several authors have financial and leadership ties to Biosyft, LLC, a company in a related technology space.
- The update ensures transparency about author-company relationships without altering the study's original conclusions.
Source: nature.com — Marcus, 2026-09-02
Published there as: “Author Correction: Endocannabinoids facilitate reward engagement through retrograde gain control”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.